Trial reporteLife2026
Modulating task-outcome value to mitigate real-world procrastination via noninvasive brain stimulation.
Trial report in eLife, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Procrastination is a prevalent behavioral problem associated with individual health and societal productivity. A leading model posits that procrastination reflects an imbalance between task aversiveness and the pursuit of positive task outcomes, yet this theoretical framework has neither been validated in real-world settings nor effectively applied to guide interventions. To address this gap, we conducted a double-blind, randomized, sham-controlled trial. Adults with chronic procrastination received seven sessions of high-definition transcranial direct current stimulation (HD-tDCS) to the left dorsolateral prefrontal cortex (DLPFC). Using the intensive experience sampling method, we assessed the effect of anodal HD-tDCS on real-world procrastination behavior at offline after-effect (2-day interval) and long-term after-effect (6-month follow-up). This neuromodulation produced a lasting reduction in real-world procrastination, with effects sustained at a 6-month follow-up. The mediation analysis indicated that increased outcome value, but not reduced task aversiveness, statistically accounted for variation in behavioral improvement. These findings are consistent with the hypothesis that enhancing DLPFC function may reduce procrastination by selectively amplifying the valuation of future rewards, not by reducing negative feelings about the task, which also suggests a targeted, theory-informed avenue for future behavioral interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.